YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 17, Pages 2247-2265
Publisher
Springer Nature
Online
2015-09-14
DOI
10.1038/onc.2015.288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
- (2015) Amir A. Jazaeri et al. NEOPLASIA
- YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors
- (2014) David Fu et al. ENDOCRINE-RELATED CANCER
- A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
- (2014) Cheryl A Sherman-Baust et al. JOURNAL OF PATHOLOGY
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- Coming into focus: the nonovarian origins of ovarian cancer
- (2013) L. Dubeau et al. ANNALS OF ONCOLOGY
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- CDK1 Phosphorylation of YAP Promotes Mitotic Defects and Cell Motility and Is Essential for Neoplastic Transformation
- (2013) S. Yang et al. CANCER RESEARCH
- The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
- (2013) Hui Cai et al. Cell Communication and Signaling
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- FGFR signalling in women's cancers
- (2013) Abbie E. Fearon et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
- (2013) Randy Johnson et al. NATURE REVIEWS DRUG DISCOVERY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization
- (2013) C Wang et al. Cell Death & Disease
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications
- (2012) Weiwei Shan et al. CELL CYCLE
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Cancer of the ovary, fallopian tube, and peritoneum
- (2012) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Primary culture and immortalization of human fallopian tube secretory epithelial cells
- (2012) Alison M Karst et al. Nature Protocols
- Transforming Growth Factor Alpha (TGFα) Regulates Granulosa Cell Tumor (GCT) Cell Proliferation and Migration through Activation of Multiple Pathways
- (2012) Cheng Wang et al. PLoS One
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
- (2011) Vito Guagnano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
- (2011) A. M. Karst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis
- (2010) Elisabetta Kuhn et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
- (2010) C. A. Hall et al. CANCER RESEARCH
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- Expression of E-Cadherin and N-Cadherin in Perinatal Hamster Ovary: Possible Involvement in Primordial Follicle Formation and Regulation by Follicle-Stimulating Hormone
- (2010) Cheng Wang et al. ENDOCRINOLOGY
- The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
- (2010) K.-P. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995-2004
- (2009) M. T. Goodman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
- (2009) Celestine S Tung et al. MODERN PATHOLOGY
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator
- (2009) Ting Li et al. PHARMACEUTICAL BIOLOGY
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now